Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

NOTICIAS


08 enero 2018

Team-centred approach is best way of determining need for PFO closure

Cardiovascular News

A meta-analysis, published in The American Journal of Medicine, provides further evidence that percutaneous closure of patent foramen ovale (PFO) in patients with recent cryptogenic stroke significantly reduces the rate of recurrent stroke/transient ischaemic stroke. However, it also appears to be associated with an increased rate of atrial fibrillation/flutter. Cardiovascular News spoke to study investigator Deepak L Bhatt (Brigham and Women’s Hospital, Heart & Vascular Center. Boston, USA) about the findings.

16 enero 2018

First US commercial implants of Elunir drug-eluting stent performed

Cardiovascular News

Cordis and Medinol have announced that the first US commercial cases using the Elunir drug-eluting stent have taken place at New York-Presbyterian Hospital/Columbia University Medical Center in New York and the Piedmont Heart Institute in Atlanta (both USA). The US FDA approved the stent for the treatment of patients with narrowing in their coronary arteries and it is now being distributed to cath labs in the USA by Cordis.

12 enero 2018

Mayo Clinic using robot-assisted PCI for preclinical study on “telestenting”

Cardiovascular News

Corindus Vascular Robotics has announced that it is working with Mayo Clinic in a preclinical study about use of telestenting. A press release reports that telestenting—or the remote robotic treatment for percutaneous coronary intervention (PCI)—may enable physicians to conduct procedures from virtually any location, opening opportunities for more patients globally to receive the benefits of this lifesaving procedure.

25 enero 2018

Patients who have an in-hospital cardiac arrest at the weekend continue to have worse outcomes

Cardiovascular News

Uchenna R Ofoma (Geisinger Health System, Danville, USA) and others report in the Journal of the American College of Cardiology that patients who have a cardiac arrest during nights or weekends continue to experience lower survival compared to patients who arrest during daytime hours. They state that survival to discharge in patients who arrested during “off-hours” was an absolute 3.8% lower compared to patients who arrested during “on-hours”.

25 enero 2018

First patient enrolled in Tryton post-approval study

Cardiovascular News

According to a press release from Tryton Medical, the first patient has been enrolled in the post approval study to evaluate the Tryton side-branch stent for the treatment of coronary artery disease. R Jobe—partner of Joel Schneider (the principal investigator of the study)—performed the first case at NC Heart and Vascular in Raleigh (USA).

19 enero 2018

Next-day discharge appears safe for TAVI patients without in-hospital complications

Cardiovascular News

Patients who undergo transfemoral transcatheter aortic valve implantation (TAVI) with a minimalist approach and who are discharged the day after the procedure have similar 30-day outcomes to those who are discharged later. Furthermore, the predictors of next-day discharge include male sex, absence of atrial fibrillation, and lower serum creatinine.

09 enero 2018

First-in-human implantation of the Cordella pulmonary artery pressure sensor performed

Cardiovascular News

Endotronix has announced successful first-in-human implantation of the Cordella pulmonary artery pressure sensor and the initiation of the SIRONA first-in-human (FIH) clinical trial. Wilfried Mullens (Ziekenhuis Oost-Limburg and University Hasselt) and Matthias Dupont (Ziekenhuis Oost-Limburg), both co-investigators of the SIRONA trial, performed the first implant at the Hospital Ziekenhuis Oost-Limburg in Genk, Belgium.

09 enero 2018

Sixty-day follow-up for the MANTA US pivotal trial completed

Cardiovascular News

Essential Medical has announced the completion of the 60-day follow up for its MANTA US pivotal study. Manta is vascular closure device and is designed to close punctures ranging from 10Fr to 25Fr at femoral arterial access sites after percutaneous cardiac procedures that use a large-bore device, such as transcatheter aortic valve implantation (TAVI) and ventricular assist devices.

05 enero 2018

Miracor Medical raises €25M to support clinical and prepare commercial activities

Cardiovascular News

Miracor Medical Systems and Miracor Medical have announced the closing of € 25m as part of a Series D financing round. The new capital will be used to further develop and commercialise the PiCSO impulse system. The round was led by Ming Capital (Shenzhen, China) and co-led by a strategic investor.

05 enero 2018

Modifying procedural technique during TAVI may lower radiation exposure to patients

Cardiovascular News

Andrew Goldsweig (Division of Cardiology, University of Nebraska Medical Center, Omaha, USA) and others report in Catheterization and Cardiovascular Interventions that eight factors are associated with increased dose-area product (DAP) during transcatheter aortic valve implantation (TAVI)—including cutdown transfemoral access (vs. percutaneous access). They observe modification of procedural technique may facilitate reduction in radiation exposure.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.